Session

Response prediction in IBD (Posters)

COMPARISON OF INTESTINAL US WITH CRP, FECAL CALPROTECTIN AND THEIR COMBINATIONS TO PREDICT ENDOSCOPIC REMISSION OF UC
COMPARISON OF INTESTINAL US WITH CRP, FECAL CALPROTECTIN AND THEIR COMBINATIONS TO PREDICT ENDOSCOPIC REMISSION OF UC

USTEKINUMAB TROUGH CONCENTRATIONS ARE ASSOCIATED WITH BIOCHEMICAL OUTCOMES IN PATIENTS WITH CROHN’S DISEASE
USTEKINUMAB TROUGH CONCENTRATIONS ARE ASSOCIATED WITH BIOCHEMICAL OUTCOMES IN PATIENTS WITH CROHN’S DISEASE

BASELINE IL-23 SERUM LEVELS PREDICT THERAPEUTIC RESPONSE TO USTEKINUMAB THERAPY IN CROHN'S DISEASE. A PROSPECTIVE STUDY
BASELINE IL-23 SERUM LEVELS PREDICT THERAPEUTIC RESPONSE TO USTEKINUMAB THERAPY IN CROHN'S DISEASE. A PROSPECTIVE STUDY

PREDICTORS OF RESPONSE TO FILGOTINIB IN ULCERATIVE COLITIS: POST HOC ANALYSIS FROM THE SELECTION STUDY
PREDICTORS OF RESPONSE TO FILGOTINIB IN ULCERATIVE COLITIS: POST HOC ANALYSIS FROM THE SELECTION STUDY

IMPACT OF INFLAMMATORY BURDEN ON EFFICACY OF UPADACITINIB MAINTENANCE THERAPY IN ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 U-ACHIEVE STUDY
IMPACT OF INFLAMMATORY BURDEN ON EFFICACY OF UPADACITINIB MAINTENANCE THERAPY IN ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 U-ACHIEVE STUDY

MYELOID CELL COMPARTMENT COLLECTED BY LONGITUDINAL SINGLE CELL TRANSCRIPTION PROFILING DISENTANGLES SHARED AND BIOLOGIC-SPECIFIC PATTERNS OF EARLY REMISSION IN IBD
MYELOID CELL COMPARTMENT COLLECTED BY LONGITUDINAL SINGLE CELL TRANSCRIPTION PROFILING DISENTANGLES SHARED AND BIOLOGIC-SPECIFIC PATTERNS OF EARLY REMISSION IN IBD

TRAJECTORY MODELLING TO IDENTIFY DIFFERENT TYPES OF INDIVIDUAL RESPONSE TO THERAPY: A POST HOC ANALYSIS FROM THE SELECTION STUDY
TRAJECTORY MODELLING TO IDENTIFY DIFFERENT TYPES OF INDIVIDUAL RESPONSE TO THERAPY: A POST HOC ANALYSIS FROM THE SELECTION STUDY

BASELINE AND EARLY PREDICTORS OF RESPONSE TO RISANKIZUMAB INDUCTION AND MAINTENANCE TREATMENT IN PATIENTS WITH MODERATE TO SEVERE CROHN'S DISEASE
BASELINE AND EARLY PREDICTORS OF RESPONSE TO RISANKIZUMAB INDUCTION AND MAINTENANCE TREATMENT IN PATIENTS WITH MODERATE TO SEVERE CROHN'S DISEASE

COMPARISON OF THE RISK OF CROHN'S DISEASE POSTOPERATIVE RECURRENCE BETWEEN MODIFIED RUTGEERTS SCORE I2A AND I2B CATEGORIES: AN INDIVIDUAL PATIENT DATA META-ANALYSIS
COMPARISON OF THE RISK OF CROHN'S DISEASE POSTOPERATIVE RECURRENCE BETWEEN MODIFIED RUTGEERTS SCORE I2A AND I2B CATEGORIES: AN INDIVIDUAL PATIENT DATA META-ANALYSIS

SEX-BASED DIFFERENCES IN RESPONSE TO VEDOLIZUMAB THERAPY FOR ULCERATIVE COLITIS: A POST-HOC ANALYSIS OF VARSITY AND GEMINI-1 STUDY
SEX-BASED DIFFERENCES IN RESPONSE TO VEDOLIZUMAB THERAPY FOR ULCERATIVE COLITIS: A POST-HOC ANALYSIS OF VARSITY AND GEMINI-1 STUDY

SEX-BASED DIFFERENCES IN RESPONSE TO VEDOLIZUMAB THERAPY FOR ULCERATIVE COLITIS: A POST-HOC ANALYSIS OF VARSITY AND GEMINI-1 STUDY
SEX-BASED DIFFERENCES IN RESPONSE TO VEDOLIZUMAB THERAPY FOR ULCERATIVE COLITIS: A POST-HOC ANALYSIS OF VARSITY AND GEMINI-1 STUDY

Response prediction in IBD (Posters)  et al.

COMPARISON OF THE RISK OF CROHN'S DISEASE POSTOPERATIVE RECURRENCE BETWEEN MODIFIED RUTGEERTS SCORE I2A AND I2B CATEGORIES: AN INDIVIDUAL PATIENT DATA META-ANALYSIS
COMPARISON OF THE RISK OF CROHN'S DISEASE POSTOPERATIVE RECURRENCE BETWEEN MODIFIED RUTGEERTS SCORE I2A AND I2B CATEGORIES: AN INDIVIDUAL PATIENT DATA META-ANALYSIS

Response prediction in IBD (Posters)  et al.

BASELINE AND EARLY PREDICTORS OF RESPONSE TO RISANKIZUMAB INDUCTION AND MAINTENANCE TREATMENT IN PATIENTS WITH MODERATE TO SEVERE CROHN'S DISEASE
BASELINE AND EARLY PREDICTORS OF RESPONSE TO RISANKIZUMAB INDUCTION AND MAINTENANCE TREATMENT IN PATIENTS WITH MODERATE TO SEVERE CROHN'S DISEASE

Response prediction in IBD (Posters)  et al.

TRAJECTORY MODELLING TO IDENTIFY DIFFERENT TYPES OF INDIVIDUAL RESPONSE TO THERAPY: A POST HOC ANALYSIS FROM THE SELECTION STUDY
TRAJECTORY MODELLING TO IDENTIFY DIFFERENT TYPES OF INDIVIDUAL RESPONSE TO THERAPY: A POST HOC ANALYSIS FROM THE SELECTION STUDY

Response prediction in IBD (Posters)  et al.

MYELOID CELL COMPARTMENT COLLECTED BY LONGITUDINAL SINGLE CELL TRANSCRIPTION PROFILING DISENTANGLES SHARED AND BIOLOGIC-SPECIFIC PATTERNS OF EARLY REMISSION IN IBD
MYELOID CELL COMPARTMENT COLLECTED BY LONGITUDINAL SINGLE CELL TRANSCRIPTION PROFILING DISENTANGLES SHARED AND BIOLOGIC-SPECIFIC PATTERNS OF EARLY REMISSION IN IBD

Response prediction in IBD (Posters)  et al.

IMPACT OF INFLAMMATORY BURDEN ON EFFICACY OF UPADACITINIB MAINTENANCE THERAPY IN ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 U-ACHIEVE STUDY
IMPACT OF INFLAMMATORY BURDEN ON EFFICACY OF UPADACITINIB MAINTENANCE THERAPY IN ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 U-ACHIEVE STUDY

Response prediction in IBD (Posters)  et al.

PREDICTORS OF RESPONSE TO FILGOTINIB IN ULCERATIVE COLITIS: POST HOC ANALYSIS FROM THE SELECTION STUDY
PREDICTORS OF RESPONSE TO FILGOTINIB IN ULCERATIVE COLITIS: POST HOC ANALYSIS FROM THE SELECTION STUDY

Response prediction in IBD (Posters)  et al.

BASELINE IL-23 SERUM LEVELS PREDICT THERAPEUTIC RESPONSE TO USTEKINUMAB THERAPY IN CROHN'S DISEASE. A PROSPECTIVE STUDY
BASELINE IL-23 SERUM LEVELS PREDICT THERAPEUTIC RESPONSE TO USTEKINUMAB THERAPY IN CROHN'S DISEASE. A PROSPECTIVE STUDY

Response prediction in IBD (Posters)  et al.

USTEKINUMAB TROUGH CONCENTRATIONS ARE ASSOCIATED WITH BIOCHEMICAL OUTCOMES IN PATIENTS WITH CROHN’S DISEASE
USTEKINUMAB TROUGH CONCENTRATIONS ARE ASSOCIATED WITH BIOCHEMICAL OUTCOMES IN PATIENTS WITH CROHN’S DISEASE

Response prediction in IBD (Posters)  et al.

COMPARISON OF INTESTINAL US WITH CRP, FECAL CALPROTECTIN AND THEIR COMBINATIONS TO PREDICT ENDOSCOPIC REMISSION OF UC
COMPARISON OF INTESTINAL US WITH CRP, FECAL CALPROTECTIN AND THEIR COMBINATIONS TO PREDICT ENDOSCOPIC REMISSION OF UC

Response prediction in IBD (Posters)  et al.

Item 1 - 20 / 20
1